Phase II / III Clinical Research · Manhattan
A dedicated research site built for precise, fast, sponsor-ready trial execution.
Iteryx Clinical Research is a standalone Phase II/III site in New York, led by an experienced principal investigator and purpose-built for MASLD, metabolic, and gastrointestinal trials.
Enrolling a participant community as diverse as New York — across all five boroughs.
For participants
Join a study. Help move medicine forward.
Study-related visits and care are provided at no cost, and compensation for time and travel may be available. Participation is always voluntary, and you can withdraw at any time.
How it works
A short, no-obligation screening confirms whether a current study is a fit. We explain every step before anything begins.
What to expect
Scheduled visits, close monitoring by experienced study staff, and clear information at every stage of the trial.
Why participate
Access to investigational treatments, attentive medical oversight, and a direct role in advancing care for your community.
What we offer
A site engineered for clean, credible trial conduct.
From recruitment to regulatory readiness, Iteryx is structured to give sponsors confidence and speed from feasibility through close-out.
Dedicated Phase II/III site
Purpose-built research space in Manhattan, operationally independent and structured around trial workflow — not a clinic running studies on the side.
Experienced principal investigator
A PI with a record across 25+ industry-sponsored trials, anchored in MASLD/metabolic and gastrointestinal disease.
Built-in, representative access
Direct access to an established and highly diverse gastroenterology and metabolic patient community — immigrant, Latino, Afro-Caribbean, and multiethnic New Yorkers — with EMR-based pre-identification for efficient, representative recruitment.
On-site & partnered imaging
On-site FibroScan for non-invasive staging, with contracted ACR-accredited imaging partners for MRI, MR-elastography, and ultrasound.
Regulatory & quality
Central IRB-ready, ICH-GCP–trained personnel, and an inspection-ready regulatory architecture and SOP framework.
Fast, clean startup
Entity, banking, and central-IRB infrastructure already in place — engineered for rapid, low-friction site activation.
Therapeutic focus
Depth where it matters most.
Primary strength
MASLD / MASH & Metabolic
The core of our principal investigator's trial experience, supported by on-site non-invasive staging and a deep metabolic patient base.
- Steatohepatitis & fibrosis-staged populations
- MRI-PDFF and MR-elastography workflows
- Cardiometabolic and adjacent endpoints
Speed lane
Gastroenterology & IBD
Built on an established GI patient panel, enabling fast identification and enrollment for inflammatory bowel disease and broader GI protocols.
- Ulcerative colitis & Crohn's disease
- EMR-based pre-screening from an active panel
- General gastroenterology protocols
Representation & reach
Enrollment as diverse as New York itself.
Iteryx draws on one of the most diverse patient communities in the country — immigrant, Hispanic/Latino, Afro-Caribbean, Black, Asian, and multiethnic New Yorkers across all five boroughs. That means representative trial populations many sites can’t reach — helping sponsors meet diversity-enrollment goals while ensuring findings reflect the patients who will ultimately rely on these therapies. Rooted in Washington Heights and accessible citywide by subway and bus.
Leadership
Investigator-led, sponsor-minded.
Lincoln Hernandez, MD
Founder · Principal Investigator · Medical Director
Dr. Hernandez is a board-certified gastroenterologist with more than 20 years of experience and an Assistant Clinical Professor of Medicine at the Icahn School of Medicine at Mount Sinai, with hospital affiliations at The Mount Sinai Hospital and Mount Sinai Queens.
He trained in Internal Medicine at NYU Downtown Hospital — earning the Program Director's Award and the John T. Flynn Young Investigator Award — completed a Clinical Nutrition fellowship at NewYork-Presbyterian Hospital / Columbia University Medical Center, where he was a research fellow at Columbia's Celiac Disease Center and co-authored multiple peer-reviewed publications, and completed his gastroenterology fellowship at Tulane University School of Medicine.
He has served as Principal Investigator across 25+ industry-sponsored clinical trials — including MASLD (metabolic-associated steatotic liver disease) drug studies — with deep clinical and research expertise spanning inflammatory bowel disease, celiac disease, and advanced endoscopy. He founded Iteryx to bring that experience into a dedicated, sponsor-ready research site.
495 Fort Washington Ave · Washington Heights
Get in touch
Considering a site for your next protocol?
We welcome feasibility inquiries from sponsors and CROs, and questions from prospective participants. Tell us about your study and we'll respond promptly.